AOD-9604: What the Research Shows
Also known as: Advanced Obesity Drug 9604, Anti-Obesity Drug 9604, Tyr-hGH Fragment 177-191
A modified fragment of human growth hormone studied for fat metabolism without the growth-promoting effects of full GH.
This content is for educational purposes only and is not medical advice. Consult a qualified healthcare provider before making any health decisions. Full disclaimer
Quick Facts
Regulatory Status
Not FDA-approved. Has GRAS (Generally Recognized as Safe) status as a food additive only. Not approved as a drug.
Researched Applications
Key Research (1 studies cited)
A double blind placebo controlled study of the effects of AOD9604 in overweight and obese subjects
human rctStier H, et al. (2013) — Journal of Obesity & Weight Loss Therapy — n=300
Small RCT testing AOD-9604 in overweight subjects. Results were not statistically significant for weight loss compared to placebo.
Key finding: AOD-9604 failed to produce statistically significant weight loss compared to placebo in a clinical trial.
About this article: Written by the PeptideMark Research Team. Last reviewed 2026-03-11. All factual claims are cited to peer-reviewed sources. PubMed links open in a new tab for independent verification. Editorial methodology · Medical disclaimer
The Peptide Brief
Weekly peptide research digest. No spam.